Citation Impact
Citing Papers
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
2003 StandoutScience
Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation
2008
Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens
2008
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Fluid balance and acute kidney injury
2009
Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera
2004
Imatinib Therapy in Clonal Eosinophilic Disorders, Including Systemic Mastocytosis
2004
Acute kidney injury
2012 Standout
Mast Cells
2008
IL-15 constrains mast cell–dependent antibacterial defenses by suppressing chymase activities
2007
Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis
2015
Adenosine: an endogenous regulator of innate immunity
2003
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Pathogenesis of polycythaemia vera
1997
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
2006
A Role for G-CSF Receptor Signaling in the Regulation of Hematopoietic Cell Function but Not Lineage Commitment or Differentiation
1999
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
2001
Sepsis and Septic Shock: A History
2009
Lymphatic filariasis and onchocerciasis
2010 Standout
The role of iron in cell cycle progression and the proliferation of neoplastic cells
2002
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
2008
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Oxygen sensing by HIF hydroxylases
2004 StandoutNobel
Severe Sepsis and Septic Shock
2013 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Pyrrolidinyl‐Spirooxindole Natural Products as Inspirations for the Development of Potential Therapeutic Agents
2007 Standout
Nonresolving Inflammation
2010 Standout
Labile iron pool: the main determinant of cellular response to oxidative stress
2003
Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera
1998
Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase
2004
Enzymatic assembly of carbon–carbon bonds via iron-catalysed sp3 C–H functionalization
2018 StandoutNatureNobel
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders
2001
Understanding cardiac failure in sepsis
2014
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
2013 StandoutNobel
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
The development of allergic inflammation
2008 StandoutNature
Sepsis and septic shock
2018 Standout
Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders
2004
Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis
2005
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress
2004
R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cells
2006 StandoutNobel
Switching on kinases: oncogenic activation of BRAF and the PDGFR family
2004
Structure of a c-Kit Product Complex Reveals the Basis for Kinase Transactivation
2003
Catalytic asymmetric synthesis of chromenes and tetrahydroquinolines via sequential allylic alkylation and intramolecular Heck coupling
2012 StandoutNobel
Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria
2003
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Mast-cell responses to pathogens
2004
Protective and pathogenic functions of macrophage subsets
2011 Standout
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis
2006
Molecular basis for polycythemia
1999
Diagnostic criteria and classification of mastocytosis: a consensus proposal
2001 Standout
Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
2008 StandoutNobel
Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti‐rheumatic therapy
2007
Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression
2003
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The significant role of mast cells in cancer
2011
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Neutrophil recruitment and function in health and inflammation
2013 Standout
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Mast Cell: A Multi-Functional Master Cell
2016
Extracellular DNA traps promote thrombosis
2010 Standout
I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development
2010 StandoutNobel
Tyrosine Kinases as Targets for Cancer Therapy
2005
SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.
2003
Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene.
1996 StandoutNobel
Normoxic Stabilization of Hypoxia-Inducible Factor-1α by Modulation of the Labile Iron Pool in Differentiating U937 Macrophages: Effect of Natural Resistance–Associated Macrophage Protein 1
2006 StandoutNobel
PROLINE HYDROXYLATION AND GENE EXPRESSION
2005 StandoutNobel
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
2004
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs
2003
Congenital and inherited polycythemia
2000
MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent Advances
2005
Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation
2000 StandoutNobel
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Detection of Overexpressed and Phosphorylated Wild-Type Kit Receptor in Surgical Specimens of Small Cell Lung Cancer
2004
Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay
2006 StandoutNobel
Comprehensive Survey of Combinatorial Library Synthesis: 2004
2005
Comparative Analysis of Mutant Tyrosine Kinase Chemical Rescue
2009 StandoutNobel
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies
2002
Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation
2000 Nobel
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Works of Frédéric Féger being referenced
Isolated and reversible impairment of ventricular relaxation in patients with septic shock*
2008
Toll‐like receptor 2 (TLR2) and TLR4 differentially activate human mast cells
2003
Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms
2003
Evolution and significance of circulating procalcitonin levels compared with IL-6, TNFα and endotoxin levels early after thermal injury
1997
The role of mast cells in host defense and their subversion by bacterial pathogens
2002
Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines
1998
Acute left ventricular dilatation and shock-induced myocardial dysfunction*
2009
Murine Pluripotent Hematopoietic Progenitors Constitutively Expressing a Normal Erythropoietin Receptor Proliferate in Response to Erythropoietin without Preferential Erythroid Cell Differentiation
1994
Ectopic Expression of the Erythropoietin Receptor in a Murine Interleukin-6–Dependent Plasmacytoma Cell Line (TEPC-2027) Confers Proliferative Responsiveness to Erythropoietin
1997
Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies
1996
Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation.
1994
Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide.
2001
Kit and <i>c-kit</i> Mutations in Mastocytosis: A Short Overview with Special Reference to Novel Molecular and Diagnostic Concepts
2002
Solid-phase synthesis and evaluation of libraries of substituted 4,5-dihydropyridazinones as vasodilator agents
2004
c-Kit and c-kit mutations in mastocytosis and other hematological diseases
2000